Regression of Iris Metastasis After Systemic Treatment With Melanoma-Targeted Therapy

JAMA Ophthalmol. 2017 Feb 9;135(2):e165462. doi: 10.1001/jamaophthalmol.2016.5462. Epub 2017 Feb 9.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Azetidines / administration & dosage
  • Humans
  • Iris Neoplasms / drug therapy*
  • Iris Neoplasms / secondary
  • Male
  • Melanoma / drug therapy*
  • Melanoma / secondary
  • Piperidines / administration & dosage
  • Protein Kinase Inhibitors / therapeutic use*
  • Remission Induction
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Vemurafenib / administration & dosage

Substances

  • Azetidines
  • Piperidines
  • Protein Kinase Inhibitors
  • Vemurafenib
  • cobimetinib